ResearcherTel Aviv UniversityActive in the last 2 years

Ronit Satchi‐Fainaro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7360-7837; OpenAlex author ID A5061202040. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 7

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Daniella Vaskovich‐Koubi · 2 shared papers, 2025–2026 · strength 0.49
- Paper Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenviro… DOI 10.1016/j.addr.2025.115670 ↗
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Guy Lahat · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Lior Orbach · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Helena F. Florindo · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Dov Hershkovitz · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Hadas Gibori · 1 shared paper, 2018 · strength 0.07
- Paper Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic can… DOI 10.1038/s41467-017-02283-9 ↗
Talia Golan · 1 shared paper, 2018 · strength 0.07
- Paper Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic can… DOI 10.1038/s41467-017-02283-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.